Notification
No new Notification messages
Zinka Logistics Solutions IPO is Open!
Apply for the Zinka Logistics Solutions IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
lyka labs ltd stock

LYKA LABS LTD Share Price

141.6 -1.70 (-1.18%)
Nov 21 2024 03:30 PM Pharmaceuticals NSE: LYKALABS

LYKA LABS LTD Share Price Update

As of the latest trading session, LYKA LABS LTD share price is currently at 141.6, which is down by -1.70 from its previous closing. Today, the stock has fluctuated between 140.10 and 145.00. Over the past year, LYKA LABS LTD has achieved a return of 10.74 %. In the last month alone, the return has been 0.97 %. Read More...

LYKA LABS LTD Performance

Day Range

Low140.10 High145.00
141.60

52 Week Range

Low 97.90 High 172.50
141.60

LYKA LABS LTD Share Price

2028

500259

LYKALABS

img img img img
No Data Available

Open Price

145.00

Prev. Close

143.31

Volume (Shares)

69018.00

Total traded value

97.72

Upper Circuit

171.97

Lower Circuit

114.64

Note: The current prices & values are delayed, Login to your account for live updates.

LYKA LABS LTD Fundamentals


(Standalone)

Market Cap (Cr) 468.55
PE Ratio (TTM) 126.85
Book Value / Share 36.63
Beta 0.94
ROE 0.00%
EPS (TTM) 1.11
Dividend Yield 0.00%
Net Profit Qtr (Cr) 2.47

LYKA LABS LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 41.16
Operating Expense 38.02
Net Profit 2.47
Net Profit Margin (%) 6.00
Earnings Per Share (EPS) 0.69
EBITDA 5.47
Effective Tax Rate (%) 24.46
Particulars JUN 2024 (Values in Cr)
Revenue 30.10
Operating Expense 28.38
Net Profit 1.75
Net Profit Margin (%) 5.81
Earnings Per Share (EPS) 0.49
EBITDA 4.68
Effective Tax Rate (%) 25.53
Particulars MAR 2024 (Values in Cr)
Revenue 26.98
Operating Expense 28.58
Net Profit -1.62
Net Profit Margin (%) -6.00
Earnings Per Share (EPS) 0.50
EBITDA 2.60
Effective Tax Rate (%) -33.88
Particulars DEC 2023 (Values in Cr)
Revenue 31.42
Operating Expense 29.54
Net Profit 1.36
Net Profit Margin (%) 4.32
Earnings Per Share (EPS) 0.40
EBITDA 6.38
Effective Tax Rate (%) 43.33
Particulars SEP 2023 (Values in Cr)
Revenue 26.76
Operating Expense 27.46
Net Profit -0.29
Net Profit Margin (%) -1.08
Earnings Per Share (EPS) -0.10
EBITDA 4.18
Effective Tax Rate (%) 34.09
Particulars MAR 2024 (Values in Cr)
Revenue 106.40
Operating Expense 108.92
Net Profit -2.27
Net Profit Margin (%) -2.13
Earnings Per Share (EPS) -0.72
EBITDA 16.16
Effective Tax Rate (%) -144.08
Particulars MAR 2023 (Values in Cr)
Revenue 80.59
Operating Expense 90.08
Net Profit -13.29
Net Profit Margin (%) -16.49
Earnings Per Share (EPS) -4.65
EBITDA 11.87
Effective Tax Rate (%) -0.60
Particulars MAR 2022 (Values in Cr)
Revenue 164.35
Operating Expense 102.16
Net Profit 39.90
Net Profit Margin (%) 24.27
Earnings Per Share (EPS) 13.87
EBITDA 95.55
Effective Tax Rate (%) 33.76
Particulars MAR 2021 (Values in Cr)
Revenue 62.26
Operating Expense 81.44
Net Profit -14.46
Net Profit Margin (%) -23.22
Earnings Per Share (EPS) -5.08
EBITDA 15.20
Effective Tax Rate (%) 21.41
Particulars MAR 2020 (Values in Cr)
Revenue 40.74
Operating Expense 70.74
Net Profit -55.39
Net Profit Margin (%) -135.95
Earnings Per Share (EPS) -19.48
EBITDA -28.37
Effective Tax Rate (%) -0.43
Particulars MAR 2024 (Values in Cr)
Book Value / Share 17.86
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.14
EBITDA Margin 15.44
Particulars MAR 2023 (Values in Cr)
Book Value / Share 9.12
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 3.36
EBITDA Margin 21.75
Particulars MAR 2022 (Values in Cr)
Book Value / Share 4.65
ROE % 77.59
ROCE % 40.57
Total Debt to Total Equity 0.00
EBITDA Margin 53.20
Particulars MAR 2021 (Values in Cr)
Book Value / Share -8.99
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 23.33
Particulars MAR 2020 (Values in Cr)
Book Value / Share -5.00
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 7.82
EBITDA Margin -0.97
Particulars MAR 2024 (Values in Cr)
Book Value / Share 27.28
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.73
EBITDA Margin 15.18
Particulars MAR 2023 (Values in Cr)
Book Value / Share 19.22
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.64
EBITDA Margin 23.64
Particulars MAR 2022 (Values in Cr)
Book Value / Share 15.49
ROE % 58.27
ROCE % 35.98
Total Debt to Total Equity 5.77
EBITDA Margin 58.14
Particulars MAR 2021 (Values in Cr)
Book Value / Share 1.54
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 12.15
EBITDA Margin 24.41
Particulars MAR 2020 (Values in Cr)
Book Value / Share 6.55
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.91
EBITDA Margin -1.52
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 5.94
Total Assets 156.72
Total Liabilities 156.72
Total Equity 68.26
Share Outstanding 33090000
Price to Book Ratio 3.88
Return on Assets (%) -1.58
Return on Capital (%) -1.99
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 11.71
Total Assets 151.52
Total Liabilities 151.52
Total Equity 45.67
Share Outstanding 30690000
Price to Book Ratio 5.45
Return on Assets (%) -8.71
Return on Capital (%) -11.26
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 17.05
Total Assets 185.61
Total Liabilities 185.61
Total Equity 13.49
Share Outstanding 28690000
Price to Book Ratio 8.75
Return on Assets (%) 21.01
Return on Capital (%) 27.25
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 7.15
Total Assets 190.01
Total Liabilities 190.01
Total Equity -25.09
Share Outstanding 28690000
Price to Book Ratio 16.88
Return on Assets (%) -6.08
Return on Capital (%) -8.45
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 10.30
Total Assets 200.16
Total Liabilities 200.16
Total Equity -15.11
Share Outstanding 28690000
Price to Book Ratio 1.95
Return on Assets (%) -30.24
Return on Capital (%) -48.28
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 5.88
Total Assets 185.88
Total Liabilities 185.88
Total Equity 99.32
Share Outstanding 33090000
Price to Book Ratio 3.88
Return on Assets (%) -1.22
Return on Capital (%) -1.46
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 8.69
Total Assets 178.85
Total Liabilities 178.85
Total Equity 76.42
Share Outstanding 30690000
Price to Book Ratio 5.45
Return on Assets (%) -7.42
Return on Capital (%) -9.01
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 15.38
Total Assets 208.51
Total Liabilities 208.51
Total Equity 44.43
Share Outstanding 28690000
Price to Book Ratio 8.75
Return on Assets (%) 19.13
Return on Capital (%) 23.11
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 6.52
Total Assets 213.37
Total Liabilities 213.37
Total Equity 4.40
Share Outstanding 28690000
Price to Book Ratio 16.88
Return on Assets (%) -6.77
Return on Capital (%) -8.73
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 8.40
Total Assets 221.26
Total Liabilities 221.26
Total Equity 18.77
Share Outstanding 28690000
Price to Book Ratio 1.95
Return on Assets (%) -25.03
Return on Capital (%) -35.72
Particulars MAR 2024 (Values in Cr)
Net Income -0.93
Cash from Operations 3.29
Cash from Investing -9.48
Cash from Financing 1.95
Net change in Cash -5.76
Free Cash Flow 12.52
Particulars MAR 2023 (Values in Cr)
Net Income -13.17
Cash from Operations 8.74
Cash from Investing 7.35
Cash from Financing -21.64
Net change in Cash -5.33
Free Cash Flow 16.93
Particulars MAR 2022 (Values in Cr)
Net Income 59.24
Cash from Operations 80.16
Cash from Investing -6.17
Cash from Financing -63.17
Net change in Cash 9.89
Free Cash Flow 87.67
Particulars MAR 2021 (Values in Cr)
Net Income -14.14
Cash from Operations 9.61
Cash from Investing -0.16
Cash from Financing -11.79
Net change in Cash -3.14
Free Cash Flow 10.88
Particulars MAR 2020 (Values in Cr)
Net Income -61.87
Cash from Operations 4.82
Cash from Investing -0.10
Cash from Financing 3.38
Net change in Cash 8.59
Free Cash Flow 5.92
Particulars MAR 2024 (Values in Cr)
Net Income -0.93
Cash from Operations 4.55
Cash from Investing -8.60
Cash from Financing 2.70
Net change in Cash -2.80
Free Cash Flow 13.79
Particulars MAR 2023 (Values in Cr)
Net Income -13.20
Cash from Operations 7.28
Cash from Investing 6.76
Cash from Financing -20.32
Net change in Cash -6.68
Free Cash Flow 16.11
Particulars MAR 2022 (Values in Cr)
Net Income 60.24
Cash from Operations 77.08
Cash from Investing -4.32
Cash from Financing -63.35
Net change in Cash 8.85
Free Cash Flow 83.00
Particulars MAR 2021 (Values in Cr)
Net Income -18.39
Cash from Operations 6.47
Cash from Investing 0.12
Cash from Financing -7.75
Net change in Cash -1.87
Free Cash Flow 7.73
Particulars MAR 2020 (Values in Cr)
Net Income -55.15
Cash from Operations -12.21
Cash from Investing 0.12
Cash from Financing 19.60
Net change in Cash 8.28
Free Cash Flow -11.64
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 55.85 32.10 3.04 428.00 37.54 / 77.70
BLISS GVS PHARMA LTD 120.75 15.11 1.25 1271.52 92.25 / 148.95
CIPLA LTD 1471.35 25.74 4.18 118825.56 1165.10 / 1702.00
FERMENTA BIOTECH LIMITED 331.20 115.00 3.35 974.75 145.00 / 354.60
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 55.85 48.57 9.49 428.00 37.54 / 77.70
AMRUTAJAN HEALTH LTD 720.90 43.85 6.99 2084.17 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6497.50 126.19 23.91 16243.75 4050.15 / 8139.85
BLISS GVS PHARMA LTD 120.75 15.72 1.24 1271.52 92.25 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 142.60
  • 26 Days 144.80
  • 10 Days 144.60
  • 50 Days 147.60
  • 12 Days 144.60
  • 100 Days 136.60
  • 20 Days 143.90
  • 200 Days 122.70
142.54
PIVOT
First Resistance 145.70
Second Resistance 150.10
Third Resistance 153.26
First Support 138.14
Second Support 134.98
Third Support 130.58
RSI 49.96
MACD -0.18
Commodity Channel Index (CCI) -0.54
ADX 13.76
Williams % R -71.32

Over 1 Month

down

0.97

Over 3 Months

down

17.41

Over 6 Months

down

23.70

Over 1 Year

down

10.74

Over 3 Years

down

5.36

Over 5 Years

down

52.28

LYKA LABS LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

LYKA LABS LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
41.73
Promoter Holdings
58.1
FII
0.15
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Ipca Laboratories Limited Shareholding of Promoter and Promoter Group 1.4624923E7 40.98
Kunal Narendra Gandhi Shareholding of Promoter and Promoter Group 2425000.0 6.79
Nehal Narendra Gandhi Shareholding of Promoter and Promoter Group 2330000.0 6.53
Enai Trading And Investment Pvt. Ltd Shareholding of Promoter and Promoter Group 1000000.0 2.8
Thermo Pads Private Limited Public Shareholding 629584.0 1.76
Pranay Godha Shareholding of Promoter and Promoter Group 300000.0 0.84
Lyka Generics Limited Shareholding of Promoter and Promoter Group 20000.0 0.06
Premchand Godha Shareholding of Promoter and Promoter Group 10900.0 0.03
Usha Premchand Godha Shareholding of Promoter and Promoter Group 10686.0 0.03
Neetu Godha Shareholding of Promoter and Promoter Group 10000.0 0.03
Bhawna Godha Shareholding of Promoter and Promoter Group 6000.0 0.02

LYKA LABS LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About LYKA LABS LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by LYKA LABS LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Lyka Labs Ltd?

Answer Field

The share price of Lyka Labs Ltd for NSE is ₹ 141.6 and for BSE is ₹ 141.2.

What is the Market Cap of Lyka Labs Ltd?

Answer Field

The market cap of Lyka Labs Ltd for NSE is ₹ 4,68.55 Cr. and for BSE is ₹ 4,67.23 Cr. as of now.

What is the 52 Week High and Low of Lyka Labs Ltd?

Answer Field

The 52 Week High and Low of Lyka Labs Ltd for NSE is ₹ 172.50 and ₹ 97.90 and for BSE is ₹ 172.65 and ₹ 99.95.

How to Buy Lyka Labs Ltd share?

Answer Field

You can trade in Lyka Labs Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Lyka Labs Ltd?

Answer Field

The 1 year returns on the stock has been 10.74%.

What is the Current Share Price of Lyka Labs Ltd?

Answer Field

Lyka Labs Ltd share price is for NSE ₹ 141.6 & for BSE ₹ 141.2 as on Nov 21 2024 03:30 PM.

What is the Market Cap of Lyka Labs Ltd Share?

Answer Field

The market cap of Lyka Labs Ltd for NSE ₹ 4,68.55 & for BSE ₹ 4,67.23 as on Nov 21 2024 03:30 PM.

What is the P/E Ratio of Lyka Labs Ltd Share?

Answer Field

As on Nov 21 2024 03:30 PM the price-to-earnings (PE) ratio for Lyka Labs Ltd share is 126.85.

What is the PB ratio of Lyka Labs Ltd Share?

Answer Field

As on Nov 21 2024 03:30 PM, the price-to-book (PB) ratio for Lyka Labs Ltd share is 36.63.

How to Buy Lyka Labs Ltd Share?

Answer Field

You can trade in Lyka Labs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Lyka Labs Ltd Share on Bajaj Broking App?

Answer Field

To buy Lyka Labs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Lyka Labs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader